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Exploring the clinical outcome 
of Mindfulness-Based Cognitive Therapy 
for bipolar and unipolar depressive patients 
in routine clinical practice: a pilot study
I. Hanssen1,2* , M. I. van Dord1, F. R. Compen1,2, D. E. M. Geurts1,2, M. P. J. Schellekens1,3 and A. E. M. Speckens1,2
Abstract 
Background: Mindfulness Based Cognitive Therapy (MBCT) has been adopted as an evidence-based treatment for 
unipolar depressive disorder (UDD). Although MBCT has not been included in the treatment guidelines for bipolar dis-
order (BD), MBCT is regularly being offered to patients with BD in routine clinical practice. In this pilot study we used 
routine outcome monitoring (ROM) data to explore whether there are indications that patients with BD might benefit 
less from MBCT than patients with UDD in terms of feasibility and effectiveness.
Methods: The study population consisted of patients with BD (n = 30) or UDD (n = 501) who received MBCT at 
the Radboudumc Centre for Mindfulness in Nijmegen, the Netherlands. Patients completed self-report measures of 
depressive symptom severity, worry, well-being, mindfulness skills and self-compassion pre- and post MBCT as part of 
the ROM.
Results: There were significant less patients with BD who decided to start MBCT after intake than patients with UDD. 
No differences in dropout between groups were found. Results showed significant moderate to large improvements 
in both groups after MBCT, while no differences between groups were found, on all outcome measures.
Conclusions: This study demonstrates that there are no indications that MBCT, when delivered in heterogeneous 
patient groups in routine clinical practice, is less beneficial for patients with BD than patients with UDD in terms of 
feasibility and effectiveness. This lends support to conduct an adequately powered RCT to examine the (cost-)effec-
tiveness of MBCT in BD as the next step before implementing MBCT on a larger scale in patients with BD.
Keywords: Mindfulness Based Cognitive Therapy, Bipolar disorder, Unipolar depressive disorder, Feasibility, 
Effectiveness
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Background
Bipolar disorder (BD) is a severe, chronic condition that 
belongs to the leading causes of disability worldwide 
(Ferrari et al. 2016). Despite multiple available evidence-
based pharmacological and psychological interventions 
for bipolar disorder, treatment outcomes are modest at 
best, as a result of which patients with bipolar disorder 
often do not achieve full remission and experience sub-
stantial residual mood symptoms between episodes 
(Chisholm et  al. 2005; Judd et  al. 2003). Augmenting, 
evidence-based psychotherapies are necessary in order 
to improve treatment outcome for patients with bipo-
lar disorder. Lately, there is an increasing interest in the 
potential of mindfulness-based approaches to improve 
outcomes of patients with several psychiatric conditions 
(Chu et al. 2018).
Mindfulness-Based Cognitive Therapy (MBCT) inte-
grates elements of cognitive therapy with meditative 
practices. Patients develop the capacity to become aware 
Open Access
*Correspondence:  imke.hanssen@radboudumc.nl
1 Department of Psychiatry, Centre for Mindfulness, Radboud University 
Medical Centre, Postbus 9101, 6500 HB Nijmegen, The Netherlands
Full list of author information is available at the end of the article
Page 2 of 10Hanssen et al. Int J Bipolar Disord            (2019) 7:18 
of distressing thoughts, emotions, and bodily sensations 
in a non-judgmental way, which helps them to disen-
gage from dysfunctional habit patterns (Segal et al. 2012). 
MBCT was originally developed to prevent depressive 
relapse in unipolar depressive disorder (UDD) and has 
been shown effective in reducing relapse (e.g. Kuyken 
et  al. 2016), as well as in reducing subsyndromal and 
acute depressive symptoms (Kingston et  al. 2007; van 
Aalderen et al. 2012). Therefore, the National Institute of 
Clinical Excellence (NICE) (2018) recommends MBCT 
as a relapse prevention approach for unipolar depres-
sive patients with a history of three or more depressive 
episodes.
Although MBCT has not yet been included as a treat-
ment option in the NICE-guidelines for bipolar disorder, 
it is regularly being offered to patients with bipolar disor-
der in routine clinical practice (Bos et al. 2014). Several 
previous studies have investigated the clinical effective-
ness of MBCT in bipolar disorder (Deckersbach et  al. 
2012; Miklowitz et al. 2009; Williams et al. 2008; Perich 
et  al. 2013; Weber et  al. 2010, 2017), and, despite lim-
ited sample sizes, results seem to support the possible 
application of MBCT in patients with bipolar disorder. 
A recent systematic literature review suggested a posi-
tive effect of MBCT on residual depression, anxiety, and 
mood regulation, while it did not appear to precipitate 
manic symptoms (Lovas and Schuman-Olivier 2018). 
However, the feasibility and effectiveness of MBCT for 
bipolar disorder was only studied in small, underpowered 
studies (Lovas and Schuman-Olivier 2018).
In order to address this issue, the present pilot study 
examined the feasibility and effectiveness of MBCT in 
patients with bipolar disorder as compared to those with 
unipolar depressive disorder in a naturalistic cohort in 
routine clinical practice. Our aim was to explore whether 
there are any indications that MBCT for bipolar disor-
der might result in a higher dropout or a reduced effec-
tiveness in terms of depressive symptom severity, worry, 
well-being, mindfulness skills, and self-compassion com-
pared to patients with unipolar depressive disorder.
Methods
Participants
The study population consisted of a naturalistic cohort 
of patients with either bipolar or unipolar depressive 
disorder (18+ years old) as assessed with the Mini Inter-
national Neuropsychiatric Interview Plus (M.I.N.I Plus) 
(Sheehan et  al. 1998). Patients received MBCT at the 
Radboudumc Centre for Mindfulness in Nijmegen, the 
Netherlands, between July 2012 and June 2016. Patients 
were referred to the Centre for Mindfulness by either 
their general practitioner or their attending psychologist 
or psychiatrist.
Procedure
During a diagnostic clinical assessment by means of 
the M.I.N.I Plus (Sheehan et  al. 1998), it was checked 
whether MBCT seemed suitable, or whether other evi-
dence-based treatments were deemed more appropriate, 
such as cognitive behavioral therapy or trauma therapy. 
Patients were invited to participate in MBCT when they 
were willing to participate in a group setting, to adhere to 
homework assignments, and to be able to attend at least 
six out of eight sessions. In the Netherlands, Routine 
Outcome Monitoring (ROM) of generic and disorder-
specific outcomes is part of general clinical practice (De 
Beurs et  al. 2011). As part of the ROM, patients had to 
complete a set of measures (see below) at least 2 weeks 
prior to the start of MBCT. After the final MBCT-session, 
patients were asked to complete the measures on site for 
a second time. Therefore, there were 11  weeks between 
pre- and post-assessment in total. We received approval 
from the ethical committee of Radboudumc to use these 
anonymized data for research purposes (CWOnr = 2015 
1972).
Measures
Self-report measures were used to assess depressive 
symptom severity, worry, well-being, mindfulness skills 
and self-compassion. Depressive symptom severity was 
measured with the 21-item Beck Depression Inventory 
(BDI-II) (Beck et  al. 1996). Worry was measured with 
the 16-item Penn State Worry Questionnaire (PSWQ) 
(Meyer et  al. 1990; van Rijsoort et  al. 1999). Well-being 
in terms of symptom distress, interpersonal relations and 
social role performance were measured with the 45-item 
Outcome Questionnaire (OQ-45) (de Jong et  al. 2007; 
Lambert et  al. 1996). Mindfulness skills were measured 
with the 24-item Five Facet Mindfulness Questionnaire 
Short Form (FFMQ-SF) (Bohlmeijer et  al. 2011). Self-
compassion was measured with the 12-item Self-Com-
passion Scale-Short Form (SCS-SF) (Raes et  al. 2011). 
The psychometric properties of all instruments are con-
sidered to be adequate to good.
Intervention
In accordance with the MBCT-program originally devel-
oped by Segal, Williams and Teasdale (Segal et al. 2002), 
the group-based MBCT consisted of eight weekly 2.5  h 
sessions, a silent day between session six and seven, and 
home assignments for 30–45 min per day. Each MBCT-
group consisted of 8 to 12 participants. MBCT was being 
taught to heterogeneous patient groups, mostly consist-
ing of patients with unipolar depressive disorder, either 
currently depressed or in (partial) remission, but also 
including patients with anxiety disorder, ADHD, autism 
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or bipolar disorder. During the sessions, participants were 
offered guided meditation exercises, psycho-education, 
and dialogue about the exercises. The MBCT were taught 
by qualified teachers meeting the advanced criteria of the 
Association of Mindfulness Based Teachers in the Neth-
erlands and Flanders, which are in concordance with the 
good practice guidelines of the UK Network for Mind-
fulness-Based Teachers (2010). The competency of the 
teachers had been evaluated between ‘advanced beginner’ 
and ‘competent’ by means of the MBI-TAC (Crane et al. 
2013) in earlier randomized controlled studies conducted 
at the Centre for Mindfulness (e.g. Huijbers et  al. 2015). 
The mean teacher competency score was 3.4 (SD = 0.7, 
range 2.2–4.3) on a Likert-scale from 1 to 6.
Data analysis
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS) version 22.0 (2013) on an inten-
tion to treat basis. Descriptive statistics of clinical and 
demographic variables of patients with bipolar or uni-
polar depressive disorder were calculated and com-
pared with χ-square or ANOVA statistics. Separate 
Linear Mixed-Effects Models were used to test whether 
scores on each outcome improved from pre- to post-
treatment (within-group), and whether there were any 
indications of treatment outcome being less favorable in 
patients with bipolar versus unipolar depressive disor-
der (between group). Time, group and their interaction 
were added as fixed effects, and a random intercept for 
participants was included (to reflect differences between 
participants). Diagonal covariance structures were used. 
In addition, a sensitivity analysis was conducted includ-
ing both random intercepts and random slopes for factor 
time. Furthermore, effect sizes were calculated. Within-
group effect sizes d were calculated by dividing the dif-
ferences in outcomes over time by the standard deviation 
in the relevant group at baseline. Between-group effect 
sizes d were calculated by dividing the differences in 
outcomes between groups at post-intervention by the 
pooled standard deviation at baseline. Effect sizes of 0.20, 
0.50 and 0.80 were considered small, medium, and large, 
respectively (Cohen 1992).
Results
Demographics
Demographic and clinical characteristics of both patients 
with bipolar and unipolar depressive disorder are shown 
in Table 1. Overall, patients were often female (65.5%) and 
highly educated (55.6%). Groups did not differ in terms of 
gender, level of education, work status, or age. In terms 
of marital status, patients with bipolar disorder were sig-
nificantly more often divorced, separated, or widowed 
and patients with unipolar depressive disorder were more 
often single. In terms of clinical characteristics, there were 
no differences between patients with bipolar and unipolar 
depressive disorder in terms of being currently depressed 
or having previously received cognitive behavioral ther-
apy. Patients with bipolar disorder more often used mood 
stabilizers and antipsychotics, whilst patients with unipo-
lar depressive disorder more often used antidepressants. 
In patients with bipolar and unipolar disorder, 14 (46.7%) 
and 218 (43.5%) patients respectively suffered from co-
morbid psychiatric disorders, such as generalized anxiety 
disorder, panic disorder, post-traumatic stress disorder, 
and substance abuse (current or in past).
Feasibility and acceptance
See Fig. 1 for a flowchart of the study population. During 
the study period a total of 942 patients were referred for 
MBCT, of whom 862 (91.5%) completed the psychiatric 
assessment. Of these patients, 35 (4.1%) were diagnosed 
with bipolar and 524 (60.8%) with unipolar depressive 
disorder. Eventually, 30 (85.7%) patients with bipolar 
disorder (19 bipolar type I and 11 bipolar type II) and 
501 (95.6%) with unipolar depressive disorder started 
with MBCT. This difference was significant (η = 6.753, 
p = 0.009). The reasons for patients with bipolar disor-
der to withdraw before the start of MBCT were: advice 
to start other evidence-based treatments first, such as 
psycho-education and trauma therapy (n = 4), and hospi-
tal admission due to a severe depressive episode (n = 1). 
The proportion of patients who started MBCT and com-
pleted four or more sessions was very similar in both 
groups, 28 (93.3%) in patients with bipolar disorder and 
455 (90.8%) of those with unipolar depressive disorder. 
Reasons of the two patients with bipolar disorder to drop 
out of MBCT were lack of time and starting an alterna-
tive psychological treatment. Furthermore, two patients 
with bipolar disorder did not attend the last MBCT-ses-
sion due to severe depressive symptoms and suicidality. 
The two groups did not differ either in mean number of 
sessions patients attended: 7.27 (SD = 2.05) in patients 
with bipolar disorder and 7.88 (SD = 1.80) in those with 
unipolar depressive disorder.
Effectiveness of MBCT
Of the 531 patients who started MBCT, 383 (72.1%) 
completed the post-treatment measures, 20 (66.7%) in 
the BD and 363 (72.9%) in the MDD group (η = 0.612, 
p = 0.434). The identified reasons for the ten bipolar 
patients not to complete post-assessments were as fol-
lows; drop out (2), attended last MBCT-session but 
could not fill out the assessment on site and did not 
send back per post (3), or did not attend last MBCT-
session due to suicidality (1), severe depression (1), 
vacation (1), or unknown reasons (2).
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Table 1 Demographic and clinical characteristics
Italic numbers indicate significant difference
a Education level: low = elementary school/preparatory vocational education; intermediate = vocational education; high = pre-university high school/community 
college/university
BD
(n = 30)
Mean (SD)
MDD
(n = 501)
Mean (SD)
t p
Age 49.4 (12.6) 46.9 (13.0) − 1.467 0.143
n (%) n (%) Chi square p
Gender 1.26 0.262
Female 23 (76.7) 325 (64.9)
Male 7 (23.3) 176 (35.1)
Marital status 7.18 0.028
Single 4 (13.3) 123 (26.1)
Married/living with a partner 16 (53.3) 275 (58.3)
Divorced/separated/widowed 10 (33.3) 74 (15.7)
Educationa 1.07 0.586
Low 1 (4.3) 35 (9.3)
Intermediate 3 (13.0) 65 (17.3)
High 19 (82.6) 276 (73.4)
Work 5.65 0.227
Working or student 12 (41.4) 245 (53.5)
Unemployed 5 (17.2) 78 (17.0)
Retired 2 (6.9) 42 (9.2)
Unemployed due to illness 3 (10.3) 46 (10.0)
Incapacitated 7 (24.1) 47 (10.3)
Current depression 0.32 0.572
Yes 15 (50) 224 (44.7)
No 15 (50) 277 (55.3)
Current pharmacological treatment 4.80 0.029
Antidepressants 10 (33.3) 240 (47.9)
Mood stabilizers 19 (63.3) 1 (0.2)
Antipsychotics 10 (33.3) 40 (8.0)
Benzodiazepines 5 (17.2) 81 (16.6)
Previous non-pharmacological treatment 1.34 0.248
Cognitive (Behavioral) therapy 11 (37.9) 238 (49.0)
DSM-IV co-morbid diagnosis
Generalized anxiety disorder 2 (6.7) 36 (7.2)
Panic Disorder
 With agoraphobia 1 (3.3) 22 (4.4)
 Without agoraphobia 2 (6.7) 23 (4.6)
Post-traumatic stress disorder 3 (10.0) 16 (3.2)
Social anxiety disorder 0 (0.0) 30 (6.0)
Obsessive compulsive disorder 0 (0.0) 15 (3.0)
Alcohol abuse
 Current 1 (3.3) 13 (2.6)
 In past 4 (13.3) 19 (3.8)
Autism spectrum disorder 1 (3.3) 10 (2.0)
Attention deficit disorder 0 (0.0) 34 (6.8)
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The effectiveness of MBCT in both patients with 
bipolar and unipolar depressive disorder is shown in 
Table  2. In both groups, MBCT resulted in a signifi-
cant reduction of depressive symptoms with a moder-
ate effect size. Patients with bipolar disorder reported 
a large reduction of worry and those with unipolar 
depressive disorder a moderate reduction. Both groups 
reported significant improvements of overall well-
being, mindfulness and self-compassion following 
MBCT, with moderate effect sizes.
Reduction of depressive symptoms and improve-
ments of well-being, mindfulness, and self-compassion 
did not differ between groups. This implies that there 
was no indication of a lower effectiveness of MBCT in 
patients with bipolar disorder versus those with unipo-
lar depressive disorder, as evidenced by the absence of 
significant time by intervention interaction effects (see 
Table  2). Reductions of worry, however, tended to be 
larger in bipolar compared to unipolar patients.
Sensitivity analyses of the primary outcome (depres-
sive symptoms measures with BDI) including random 
slopes for factor time showed similar results.
Discussion
This pilot study investigated feasibility and effective-
ness of MBCT in patients with bipolar disorder com-
pared to patients with unipolar depressive disorder in 
a naturalistic cohort setting. Results show that MBCT 
seems to be a feasible and acceptable intervention for 
patients with bipolar disorder. There were significant 
less patients with bipolar disorder who decided to start 
MBCT after intake compared to patients with unipolar 
depressive disorder. No differences in dropout between 
groups were observed. Furthermore, we found signifi-
cant effects in patients with bipolar and unipolar depres-
sive disorder following MBCT on all outcome measures, 
showing reductions in depressive symptoms and worry, 
and improvements in well-being, mindfulness skills, and 
self-compassion. In addition, we did not find any indica-
tion that MBCT was less effective in patients with bipolar 
compared to patients with unipolar depressive disorder. 
These results lend support to the notion that MBCT, 
when delivered in heterogeneous patient groups, might 
be as helpful in patients with bipolar as those with unipo-
lar depressive disorder.
The finding that MBCT seems to be a feasible and 
acceptable intervention for patients with bipolar disorder 
is consistent with an earlier feasibility trial conducted by 
Weber et al. (2010). In contrast to earlier studies on the 
feasibility of MBCT for patients with bipolar disorder, the 
present study showed a much lower dropout rate. Results 
showed a dropout of only 6.6%, compared to dropout 
rates of 21–34% in the studies of Weber et al. (2010), Wil-
liams et al. (2008), and Perich et al. (2013). The low drop-
out rate found in the present study as compared to other 
scientific studies might be explained by the naturalistic 
Fig. 1 Flowchart of patients with BD and UDD
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nature of the present study. During intake, the motiva-
tion of patients is extensively assessed. Patients are only 
eligible to participate in MBCT when they indicate to be 
able to attend at least six out of eight sessions, and are 
motivated to do their homework. Furthermore, when 
other evidence-based interventions seem more suitable, 
e.g. trauma therapy, patients are advised not to follow 
MBCT yet. These considerations might be beneficial for 
other professionals as well, in order to reduce drop-out 
in interventions. Furthermore, the present study showed 
a high completion of measures, with 72% of completers 
in the present study compared to 67% in the study of Bos 
et al. (2014).
The findings that MBCT might be as helpful in patients 
with bipolar as to those with unipolar depressive disorder 
add to the growing body of evidence of controlled stud-
ies, which, although using homogeneous and restricted 
groups of patients with bipolar disorder, seem to support 
the possible application of MBCT in bipolar disorder 
(Deckersbach et  al. 2012; Miklowitz et  al. 2009; Weber 
et al. 2010). Furthermore, the results are in line with an 
earlier study of Williams et al. (2008) where MBCT was 
found equally effective in reducing depressive symptoms 
in patients with bipolar and unipolar depressive disorder 
compared to a waitlist control group. However, the study 
of Williams et al. (2008) included patients with an explicit 
history of suicidal ideation or behavior only, which limits 
the generalizability of the findings to the general popu-
lation of patients with bipolar and unipolar depressive 
disorder.
The present study found a non-significant between-
groups effect on reduction of worry. Previous studies 
have indicated that reduction of rumination might be one 
of the key underlying mechanisms of MBCT (Gu et  al. 
2015). Our results suggest that MBCT is more effective 
in reducing levels of worry in patients with bipolar dis-
order as compared with unipolar depressive disorder. 
However, clinical diagnosis is conflated with higher lev-
els of rumination. It is known that patients with bipolar 
disorder show higher levels of rumination than patients 
with unipolar depressive disorder, regardless of cur-
rently experiencing a mood episode (Kim et  al. 2012). 
In our sample, patients with bipolar disorder indeed 
showed (non-significantly) higher baseline worry than 
patients with unipolar depressive disorder. Interest-
ingly, studies show that depressive patients with higher 
baseline levels of rumination, benefit more from MBCT 
than participants with lower levels of rumination (e.g. 
Cladder-Micus et al. 2018). Future research will have to 
elucidate whether the effectiveness of MBCT is best pre-
dicted by either clinical diagnosis or baseline levels of 
rumination. The primary strength of the present study 
compared to extant literature is the inclusion of a large 
sample of unipolar depressive patients from a naturalis-
tic cohort. Furthermore, the low dropout rates and high 
completion of measures are considered to be a strength. 
However, the results of the present study should be con-
sidered in the light of several limitations as well. Firstly, 
an important limitation is the small sample of patients 
with bipolar disorder. Since this study uses a naturalistic 
sample of patients, and MBCT had not been included in 
the guidelines for bipolar disorder, but had been in the 
guidelines for unipolar depressive disorder for several 
years, this is no surprising finding. Secondly, since data of 
this study was collected as part of ROM, no measures of 
manic symptom severity were included. However, since 
we were able to identify reasons for non-completion of 
MBCT, we are able to show that MBCT did not seem 
to have precipitated mania in the patients with bipolar 
disorder who dropped out MBCT in the present study. 
Thirdly, participants in our study were mainly middle 
aged, high educated females, which limits the generaliz-
ability of our findings. Fourthly, even though the present 
study shows a similar measurement completion rate in 
comparison with other clinical trials, the missing data 
could still result in bias. However, based on the identified 
reasons for not completing post-measures, we expect this 
bias to be low. Fifthly, since no follow-up measures were 
conducted in the present study, we are unaware whether 
there might have been any adverse effects in patients fol-
lowing MBCT at the long-term. Finally, since this was an 
uncontrolled study conducted in a naturalistic setting, it 
did not include a control group.
Conclusion
This study shows that MBCT seems to be a feasible and 
acceptable intervention for patients with bipolar disorder. 
Furthermore, no indications were found that MBCT is 
less effective in patients with bipolar disorder compared 
to patients with unipolar depressive disorder. Our find-
ings have some important clinical implications. Reasons 
for non-completion of MBCT for patients with bipolar 
disorder were, amongst others, severe depression and 
suicidality. These possible adverse effects were reported 
spontaneously in the present study, since this study was 
not conducted in a controlled research setting. These 
findings underline the importance of structural monitor-
ing of adverse effects in clinical studies and the need for 
clear assessment and indication criteria for patients with 
bipolar disorder to participate in MBCT. A subsequent 
randomized controlled trial is necessary to establish the 
effectiveness of MBCT in comparison with TAU, active 
control conditions or existing evidence-based psycholog-
ical interventions, such as cognitive behavioral therapy.
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